Anastrozole

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Anastrozole and local guidelines before prescribing.

Aromatase inhibitor

Mechanism

Non-steroidal aromatase inhibitor lowering oestrogen synthesis.

Uses

Hormone receptor-positive breast cancer in postmenopausal women.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hot flushes, arthralgia, bone loss, vaginal dryness, fatigue.

Interactions

Do not combine with tamoxifen or oestrogens.

Contraindications and cautions

Premenopausal women; caution in osteoporosis

Monitoring

Bone density, lipids

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in severe renal impairment

Overdose and reversal

Supportive

Special advice

Baseline bone density and vitamin D/calcium advice; not for premenopausal women unless ovarian suppression.

More from the textbook: uses, cautions and other points
Where it is discussed in the book